Indefinite Delivery Contract SPM20005D3021

The provided information outlines an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a large, for-profit healthcare services and products company. The contract, valued at $0, is for the supply of a wide range of pharmaceutical and medical products, including prescription medications, over-the-counter drugs, vaccines, and radiopharmaceuticals, to various government agencies such as the Department of Defense (DoD), Department of Veterans Affairs (VA), and National Institutes of Health (NIH). The contract has a period of performance from January 25, 2005, to March 31, 2015.

The contract includes numerous firm fixed-price delivery orders issued under the DLA's Pharmaceutical Prime Vendor program, which provides medical supplies to military treatment facilities and deployed troops worldwide. The delivery orders cover a diverse range of pharmaceutical products, including antibiotics, pain medications, vaccines, and specialty drugs, with specific examples such as the supply of Sirturo tablets to the NIH Clinical Center and LYMPHOSEEK DOSE radiopharmaceuticals to the VA. Additionally, Cardinal Health holds a separate single-award IDC with the VA National Acquisition Center for the supply of Lurasidone Hydrochloride tablets, further demonstrating the company's capabilities in managing large-scale pharmaceutical supply agreements across multiple government agencies.